Cas 1235975-95-7,[5-(2,4-dimethoxy-benzyloxycarbamoyl)-pentyl]-carbamic acid 9H-fluoren-9-yl methyl ester

1235975-95-7

Post Buying Request

Basic information

Product Name: [5-(2,4-dimethoxy-benzyloxycarbamoyl)-pentyl]-carbamic acid 9H-fluoren-9-yl methyl ester
Synonyms: [5-(2,4-dimethoxy-benzyloxycarbamoyl)-pentyl]-carbamic acid 9H-fluoren-9-yl methyl ester
CAS NO:1235975-95-7
Molecular Formula:
Molecular Weight: 518.61
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: [5-(2,4-dimethoxy-benzyloxycarbamoyl)-pentyl]-carbamic acid 9H-fluoren-9-yl methyl ester(CAS DataBase Reference)
NIST Chemistry Reference: [5-(2,4-dimethoxy-benzyloxycarbamoyl)-pentyl]-carbamic acid 9H-fluoren-9-yl methyl ester(1235975-95-7)
EPA Substance Registry System: [5-(2,4-dimethoxy-benzyloxycarbamoyl)-pentyl]-carbamic acid 9H-fluoren-9-yl methyl ester(1235975-95-7)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1235975-95-7(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1235975-95-7 Suppliers

Recommended suppliers

1235975-95-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1235975-95-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,3,5,9,7 and 5 respectively; the second part has 2 digits, 9 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1235975-95:
(9*1)+(8*2)+(7*3)+(6*5)+(5*9)+(4*7)+(3*5)+(2*9)+(1*5)=187
187 % 10 = 7
So 1235975-95-7 is a valid CAS Registry Number.

1235975-95-7Upstream product

1235975-95-7Downstream Products

1235975-95-7Relevant academic research and scientific papers

Acylurea connected straight chain hydroxamates as novel histone deacetylase inhibitors: Synthesis, SAR, and in vivo antitumor activity

Wang, Haishan,Lim, Ze-Yi,Zhou, Yan,Ng, Melvin,Lu, Ting,Lee, Ken,Sangthongpitag, Kanda,Goh, Kee Chuan,Wang, Xukun,Wu, Xiaofeng,Khng, Hwee Hoon,Goh, Siok Kun,Ong, Wai Chung,Bonday, Zahid,Sun, Eric T.

supporting information; experimental part, p. 3314 - 3321 (2010/08/06)

Thirty-six novel acylurea connected straight chain hydroxamates were designed and synthesized. Structure-activity relationships (SAR) were established for the length of linear chain linker and substitutions on the benzoylurea group. Compounds 5g, 5i, 5n, and 19 showed 10-20-fold enhanced HDAC1 potency compared to SAHA. In general, the cellular potency pIC50 (COLO205) correlates with enzymatic potency pIC50 (HDAC1). Compound 5b (SB207), a structurally simple and close analogue to SAHA, is more potent against HDAC1 and HDAC6 compared to the latter. As a representative example of this series, good in vitro enzymatic and cellular potency plus an excellent pharmacokinetic profile has translated into better efficacy than SAHA in both prostate cancer (PC3) and colon cancer (HCT116) xenograft models.

ACYLUREA CONNECTED AND SULFONYLUREA CONNECTED HYDROXAMATES

-

Page/Page column 70, (2010/02/11)

The present invention relates to hydroxamate compounds which are inhibitors of histone deacetylase. More particularly, the present invention relates to acylurea/sulfonylurea containing compounds and methods for their preparation. These compounds may be useful as medicaments for the treatment of proliferative disorders as well as other diseases involving, relating to or associated with enzymes having histone deacetylase activities.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1235975-95-7